Barry E Greene - Net Worth and Insider Trading
Barry E Greene Net Worth
The estimated net worth of Barry E Greene is at least $20 Million dollars as of 2024-11-13. Barry E Greene is the President of Alnylam Pharmaceuticals Inc and owns about 73,501 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $20 Million. Barry E Greene is the President and CEO of Sage Therapeutics Inc and owns about 46,940 shares of Sage Therapeutics Inc (SAGE) stock worth over $268,966. Barry E Greene is also the Director of Karyopharm Therapeutics Inc and owns about 3,000 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $2,693. Besides these, Barry E Greene also holds Acorda Therapeutics Inc (ACORQ) . Details can be seen in Barry E Greene's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Barry E Greene has not made any transactions after 2022-11-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Barry E Greene
Barry E Greene Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Barry E Greene owns 6 companies in total, including BCLS Acquisition Corp (BLSA) , Sage Therapeutics Inc (SAGE) , and Alnylam Pharmaceuticals Inc (ALNY) among others .
Click here to see the complete history of Barry E Greene’s form 4 insider trades.
Insider Ownership Summary of Barry E Greene
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLSA | BCLS Acquisition Corp | 2020-10-22 | director |
| SAGE | Sage Therapeutics Inc | 2022-11-10 | director |
| ALNY | Alnylam Pharmaceuticals Inc | 2020-09-09 | COO and Treasurer |
 | | 2017-08-01 | director |
| | 2015-04-02 | director |
| | 2012-10-04 | director & 10 percent owner |
Barry E Greene Latest Holdings Summary
Barry E Greene currently owns a total of 4 stocks. Among these stocks, Barry E Greene owns 73,501 shares of Alnylam Pharmaceuticals Inc (ALNY) as of September 9, 2020, with a value of $20 Million and a weighting of 98.64%. Barry E Greene owns 46,940 shares of Sage Therapeutics Inc (SAGE) as of November 10, 2022, with a value of $268,966 and a weighting of 1.34%. Barry E Greene also owns 3,000 shares of Karyopharm Therapeutics Inc (KPTI) as of April 2, 2015, with a value of $2,693 and a weighting of 0.01%. The other 1 stocks Acorda Therapeutics Inc (ACORQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Barry E Greene
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | 2020-09-09 | 73,501 | 268.95 | 19,768,094 |
| SAGE | Sage Therapeutics Inc | 2022-11-10 | 46,940 | 5.73 | 268,966 |
| KPTI | Karyopharm Therapeutics Inc | 2015-04-02 | 3,000 | 0.90 | 2,693 |
| ACORQ | Acorda Therapeutics Inc | 2017-08-01 | 0 | 0.01 | 0 |
Holding Weightings of Barry E Greene
Barry E Greene Form 4 Trading Tracker
According to the SEC Form 4 filings, Barry E Greene has made a total of 3 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Alnylam Pharmaceuticals Inc is the sale of 44,530 shares on September 9, 2020, which brought Barry E Greene around $5 Million.
According to the SEC Form 4 filings, Barry E Greene has made a total of 2 transactions in Sage Therapeutics Inc (SAGE) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Sage Therapeutics Inc is the acquisition of 14,500 shares on November 10, 2022, which cost Barry E Greene around $499,960.
According to the SEC Form 4 filings, Barry E Greene has made a total of 0 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years. The most-recent trade in Karyopharm Therapeutics Inc is the acquisition of 3,000 shares on April 2, 2015, which cost Barry E Greene around $87,930.
More details on Barry E Greene's insider transactions can be found in the Insider Trading History of Barry E Greene table.Insider Trading History of Barry E Greene
- 1
Barry E Greene Trading Performance
GuruFocus tracks the stock performance after each of Barry E Greene's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Barry E Greene is 21.97%. GuruFocus also compares Barry E Greene's trading performance to market benchmark return within the same time period. The performance of stocks bought by Barry E Greene within 3 months outperforms 5 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Barry E Greene's insider trading performs compared to the benchmark.
Performance of Barry E Greene
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.95 | | | | | |
| Relative Return to S&P 500(%) | 11.49 | | | | | |
Barry E Greene Ownership Network
Ownership Network List of Barry E Greene
Ownership Network Relation of Barry E Greene
Barry E Greene Owned Company Details
What does BCLS Acquisition Corp do?
Who are the key executives at BCLS Acquisition Corp?
Barry E Greene is the director of BCLS Acquisition Corp. Other key executives at BCLS Acquisition Corp include director & 10 percent owner Adam Koppel , director & 10 percent owner & Chief Executive Officer Jeffrey Lawrence Schwartz , and director & 10 percent owner & Chief Financial Officer Hack Andrew A. F. .
BCLS Acquisition Corp (BLSA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BCLS Acquisition Corp (BLSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BCLS Acquisition Corp (BLSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BCLS Acquisition Corp (BLSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
BCLS Acquisition Corp Insider Transactions
Barry E Greene Mailing Address
Above is the net worth, insider trading, and ownership report for Barry E Greene. You might contact Barry E Greene via mailing address: C/o Acorda Therapeutics, 420 Saw Mill River Road, Ardsley Ny 10502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
